New first-in-human study explores immune-engineered cell therapy approach for type 1 diabetes
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1…
Read the full articleYou might also wanna read
Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months
wired.com·10mo agoTargeting GLUT1 to Control Autoimmunity in Type 1 Diabetes
Conditions : Type 1 Diabetes; Autoimmunity Sponsors : IRCCS San Raffaele Not yet recruiting
10 out of 12 people cured in Type 1 Diabetes Study
Article URL: Comments URL: Points: 15 # Comments: 2
ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
Conditions : Type 1 Diabetes Interventions : Device: ENCRT-103-hPI encompasses the ENC-103 device, which will be implanted once loaded with
BANDICOOT: An Adaptive Platform Trial to Improve Health Outcomes After Paediatric Stem Cell Transplant
Conditions : Haematopoietic Stem Cell Transplant, Allogeneic Interventions : Other: Standard care Sponsors : Murdoch Childrens Research Inst
Real-world Effectiveness and Safety of Omnipod 5 in Adults With Type 1 Diabetes: a 12-month Observational Study.
Conditions : Type 1 Diabetes Mellitus Sponsors : Papa Giovanni XXIII Hospital Completed
Comments
Sign in to join the conversation.
No comments yet. Be the first.